genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Update Preferences
Subscribe
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Biologics
Lonza and the Israel Biotech Fund Ink Development and Manufacturing Deal
Cancer
Researchers Take a Deep Dive and Discover Anticancer Compound Found in…
Neurological Disorders
Anticonvulsant Drug May Boost Functional Recovery after a Stroke
AgBio
No Sun, No Problem: CRISPR’d Tomatoes Produce Vitamin D
Aging
Mechanism Tied to Age-Related Memory Loss Identified in Rodents
Insights
All
Trends for 2020
Trends for 2021
Antibiotics
Nanotechnologies Set to Tackle Implant-Associated Infections
Cancer
New DNA Repair Mechanism Holds Promise for Precision Cancer Therapies
Gene Therapy
Francis Collins Urges Gene Therapy Community to Scale Efforts to Tackle…
Artificial Intelligence
Drug Firms That Embrace Digitization Reap Full Benefits
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Companies
Biogen
Page 2
Biogen
23andMe
Abbott
Abbvie
AC Immune
Acorda Therapeutics
AdnaGen
Agilent Technologies
Alere
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Beckman Coulter
Berkeley Lights
Bio-Rad Laboratories
Biogen
BioServe Biotechnologies
Cancer Genetics
Catalent
Chan Soon-Shiong Institute for Molecular Medicine
Charles RIver Laboratories
Color Genomics
Cynvenio Biosystem
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Invitae
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
R-Biopharm
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Stand Up to Cancer
Synthego
Takeda
Thermo Fisher Scientific
TriLink Biotechnologies
Trovagene
UCB Biosciences
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Genome Editing
Scribe Pursues CRISPR Therapies with Expanded Biogen Collaboration
Financing
StockWatch: Biogen Stays Flat Despite Positive 128-Week Aduhelm Data
Drug Discovery
Biogen Poised for Pipeline Growth, Samsung Eyes New Drug Expansion after $2.3B Joint Venture Deal
Biogen
Biogen Mulls Tofersen’s Future after Drug Misses Phase III Trial’s Primary Endpoint in ALS
Biogen
FDA Seeks Review of Staff-Biogen Talks Leading to Alzheimer’s Drug Approval
Biogen
Biogen Buys Option to TMS’ Phase II Stroke Candidate
Biogen
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
Biogen
Biogen Buys Pfizer Neuropsychiatry Candidate for Up-to-$590M+
Biogen
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA...
Biogen
Biogen Halts Development of Tysabri for Acute Ischemic Stroke after Phase...
Biogen
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
Biogen
Biogen to Develop Alkermes’ MS Candidate ALKS 8700
Biogen
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Biogen
Biogen Pays Ionis $10M as Phase I/IIa Trial Launched for Alzheimer’s...
Biogen
Biogen Acquires Stroke Candidate Cirara from Remedy for $120M Upfront
1
2
3
Page 2 of 3
Scroll Up